PetIQ

PetIQ, Inc. is a holding company, which engages in the manufacture, procurement, packaging, and distribution of pet health and wellness products. It operates through the Products and Services segments. The Products segment produces and distributes pet medication and health and wellness products to the retail channel. The Services segment represents all veterinary services, and related product sales provided by the firm directly to consumers. Its brands include Advecta, Betsy Farms, Delightibles, Tex Ranch, Mimis Market, and PetLock. The company was founded by McCord Christensen in 2010 and is headquartered in Eagle, ID.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

PetIQ reports robust Q4 performance, eyes growth through acquisitions

PetIQ delivered a strong performance in Q4 2022, showcasing growth in sales, margins, and operational efficiency across its product and service segments.
While facing challenges from consumer trade-down and integration complexities, the company's strategic focus on brand portfolio expansion and service enhancements positions it for future success.
Opportunities lie in new product introductions, service expansions, and partnership growth, indicating a positive outlook for PetIQ's continued growth trajectory.
With a solid financial foundation, strategic acquisitions, and operational improvements, PetIQ is poised to capitalize on market opportunities and drive sustainable growth.

PetIQ reports record Q1 earnings, eyes growth in premium products

PetIQ delivered strong financial performance in Q1 2023, driven by robust sales growth and operational efficiency improvements.
While facing challenges in hiring veterinarians and transitioning production, the company is well-positioned for future growth.
Opportunities lie in expanding product offerings, optimizing operations, and leveraging e-commerce for sustained growth.
Overall, PetIQ remains optimistic about future performance and is on track to meet full-year expectations.

PetIQ reports record Q2 earnings, eyes growth through innovation

PetIQ delivered strong financial performance in Q2 2023, driven by robust sales growth and operational improvements across segments.
While facing challenges in managing product mix and operational efficiency, the company remains optimistic about future growth opportunities.
By focusing on customer-centric strategies, investing in innovation, and planning significant product launches, PetIQ is well-positioned for continued success.

PetIQ reports record Q3 earnings, eyes growth through operational efficiency

PetIQ's Q3 performance exceeded expectations, driven by strong sales growth in key product categories. The company's focus on operational efficiency and strategic decision-making bode well for future success. Despite challenges in certain segments, PetIQ's outlook remains positive with opportunities for continued growth and market differentiation.

PetIQ reports strong Q4 earnings, eyes growth amid market challenges

PetIQ's Q4 2023 earnings reflect robust financial performance, strategic growth initiatives, and a positive outlook for 2024, underpinned by strong brand growth and operational efficiency.
While facing challenges such as seasonal variability and market risks, PetIQ's focus on margin expansion, disciplined acquisitions, and market positioning present opportunities for sustained success and market leadership.
With a conservative approach, emphasis on pet health and wellness products, and a clear growth strategy, PetIQ is poised for continued momentum and execution in the pet care industry.

PetIQ reports record Q1 earnings, raises guidance for 2024

PetIQ's Q1 performance exceeded expectations, driven by strong sales and margin expansion. While facing challenges such as higher expenses, the company is poised for growth with raised guidance and planned marketing investments. Leveraging opportunities in key product categories and services segment expansion will be crucial for sustained success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

PetIQ specializes in affordable veterinary services and a wide range of pet health products. The company focuses on preventive care, ensuring pet owners have convenient access to necessary treatments and medications. With integrated manufacturing and distribution capabilities, PetIQ aims to enhance pet health and wellness.

NEW YORK, May 3, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of PetIQ, Inc. (NASDAQ: PETQ). If you are a shareholder of PetIQ, Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at: http://pjlfirm.com/petiq-inc/ You may also contact Robert H.

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating PetIQ, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: PetIQ (PETQ) Q1 Earnings Expected to Decline

The number of households with pets is growing, and those pets will need care.

Could the Pandemic Pet Surge Make Investors in This Stock Rich?

EAGLE, Idaho, April 22, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for the first quarter ended March 31, 2021 on Wednesday, May 5, 2021 after the market close.

PetIQ, Inc. to Report First Quarter 2021 Financial Results on Wednesday, May 5, 2021

PetIQ (PETQ) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

PetIQ (PETQ) Surges 5.8%: Is This an Indication of Further Gains?

Increases Borrowing Capacity by Approximately $109 Million

PetIQ, Inc. Enters Into New $425 Million Credit Facilities

Heska

IDEXX Laboratories

The pandemic puppy boom is real, and so are sales for these three pet stocks.

3 Pet Med Companies Whose Growth Makes Them a Breed Apart

PetIQ, Inc.'s (PETQ) CEO Cord Christensen on Q4 2020 Results - Earnings Call Transcript

EAGLE, Idaho, Feb. 24, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the appointments of Sheryl Oloughlin and Kim Lefko as independent directors on its Board of Directors, effective March 2, 2021. These additions of Ms. Oloughlin and Ms. Lefko fill vacancies on the Company's Board of Directors and will increase the size of the Board from five to seven.

PetIQ, Inc. Appoints Two New Independent Directors with Extensive Consumer Packaged Goods and Marketing Experience

EAGLE, Idaho, Feb. 23, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that management will participate in the Raymond James 42nd Annual Institutional Investors Conference.

PetIQ, Inc. to Participate in the Raymond James 42nd Annual Institutional Investors Conference

EAGLE, Idaho, Feb. 11, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for the fourth quarter and full year ended December 31, 2020 on Thursday, February 25, 2021 after the market close.

PetIQ, Inc. to Report Fourth Quarter and Full Year 2020 Results on Thursday, February 25, 2021

PetIQ has been an acquisition machine since it went public in 2017. The company operates in a compelling and growing industry, yet leverage is high and earnings are complicated.

PetIQ: Smart Here?

Chewy

Freshpet

PetMed Express

Trupanion

Zomedica

Pet stocks have performed very well recently, and many analysts believe that this trend will continue as the industry grows. The post 7 Pet Stocks for Animal Lovers and Investors Alike appeared first on InvestorPlace.

7 Pet Stocks for Animal Lovers and Investors Alike

Church & Dwight

Lemonade

Zoetis

Americans love their pets, and no pandemic, not even the novel coronavirus, will change that, bolstering these eight pet stocks. The post 8 Pet Stocks That Will Make You Purr appeared first on InvestorPlace.

8 Pet Stocks That Will Make You Purr

EAGLE, Idaho, Nov. 10, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that management will participate in the Jefferies Virtual West Coast Consumer Conference.

PetIQ, Inc. to Participate in the Jefferies Virtual West Coast Consumer Conference

PetIQ, Inc. (PETQ) CEO Cord Christensen on Q3 2020 Results - Earnings Call Transcript

PetIQ (PETQ) delivered earnings and revenue surprises of -168.75% and -2.89%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

PetIQ (PETQ) Reports Q3 Loss, Lags Revenue Estimates

EAGLE, Idaho, Nov. 05, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the three and nine months ended September 30, 2020.

PetIQ, Inc. Reports Third Quarter 2020 Financial Results

PetIQ (PETQ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Can PetIQ (PETQ) Keep the Earnings Surprise Streak Alive?

PetIQ (PETQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PetIQ (PETQ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

EAGLE, Idaho, Oct. 22, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for the third quarter ended September 30, 2020 on Thursday, November 5, 2020 after the market close.

PetIQ, Inc. to Report Third Quarter 2020 Results on Thursday, November 5, 2020

Remains On-track for 95% of Services Segment to be Open by the End of the Third Quarter Remains On-track for 95% of Services Segment to be Open by the End of the Third Quarter

PetIQ, Inc. Provides Update on Wellness Center Reopening Plan

PetIQ shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
The post Stock Upgrades: PetIQ Shows Rising Relative Strength appeared first on Investor's Business Daily.

Stock Upgrades: PetIQ Shows Rising Relative Strength

PetIQ's (PETQ) CEO Cord Christensen on Q2 2020 Results - Earnings Call Transcript

The company achieved record revenue in the second quarter, but is guiding for declines.

News for PetIQ Stock (PETQ)